跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 15 条关于
“NeuCeno”
全部
15
临床试验
2
药物
4
机构
2
资讯
7
前天
Alkem Launches NeuCeno (cenobamate) in India, First Availability of the Anti-Seizure Drug for Partial-Onset Seizures
去年
Neuren Pharmaceuticals Launches First-Ever Phase 3 Trial for Phelan-McDermid Syndrome
去年
Imugene's Azer-Cel Trial Opens First Australian Site; Neuren's Daybue Sales Exceed Expectations
去年
Neuren Pharmaceuticals Secures US Patent for NNZ-2591 in Pitt Hopkins Syndrome Treatment
11个月前
Neuren Pharmaceuticals Receives FDA Fast Track Designation for NNZ-2591 in Rare Neurological Syndromes
去年
Neuren Pharmaceuticals Reports Record DAYBUE Royalties as Rett Syndrome Therapy Sales Exceed $100 Million Quarterly Milestone
9个月前
Neuren Pharmaceuticals Advances First-Ever Phase 3 Trial for Phelan-McDermid Syndrome with Promising Phase 2 Results